Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-20-001968

Options or other derivatives

  • Director acquired 46,559 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Keyes Jeffry R. Director 2020-06-12 Grant or award · Option to purchase common stock +46,559 146,559 D: show line 1 in the form
Loading xslF345X03/ownership.xml…